Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

British Journal of Cancer

Volumn 80, Issue 8, 1999, Pages 1252-1258

  Qiu, L ^a   Kelso, M J ^b   Hansen, C ^a   West, M L ^b   Fairlie, D P ^b   Parsons, P G ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Differentiating agents; Histone acetylation; Melanoma

Indexed keywords

ANTINEOPLASTIC AGENT; HISTONE H4; HYDROXAMIC ACID DERIVATIVE; PHOSPHATASE; PROTEIN; RNA; TRICHOSTATIN A;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SYNTHESIS; TUMOR XENOGRAFT;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; DENDRITIC CELLS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYDROXAMIC ACIDS; MELANOMA; MICE; MICE, NUDE; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0032989027     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690493     Document Type: Article

References (31)

1. Andreeff M, Stone R, Michaeli J, Young CW, Tong WP, Sogoloff H, Ervin, T, Kufe D, Rifkind RA and Marks PA (1992) Hexamethylene bis acetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiating agent. Blood 80: 2604-2609
2. Beere HM and Hickman JA (1993) Differentiation: a suitable strategy for cancer chemotherapy? Anticancer Drug Des 8: 299-322
3. Boulikas T (1994) A compilation and classification of DNA binding sites for protein transcription factors from vertebrates. Crit Rev Euk Gene Exp 4: 117-321
4. Breslow R, Jursic B, Yan ZF, Friedman E, Leng, L, Ngo L, Rifkind RA and Marks PA (1991) Potent cytodifferentiating agents related to hexamethylenebisacetamide. Proc Natl Acad Sci USA 88: 5542-5546
5. Chen TR (1977) In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res 104: 255-262
6. Hoshikawa Y, Kwon HJ, Yoshida M, Horinouchi S and Beppu T (1994) Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res 214: 189-197
7. Kijima M, Yoshida M, Sugita K, Horinouchi S and Beppu T (1993) Trapoxin is an irreversible inhibitor of mammalian histone deacetylase. J Biol Chem 268: 22429-22435
8. Kiyokawa H, Richon VM, Rifkind RA and Marks PA (1994) Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 14: 7195-7203
9. Marks PA, Richon VM, Kiyokawa H and Rifkind RA (1994) Inducing differentiation of transformed cells with hybrid polar compounds: a cell-cycle dependent process. Proc Natl Acad Sci USA 91: 10251-10254
10. Maynard K and Parsons PG (1986) Cross sensitivity to methylating agents, hydroxyurea and methotrexate in human tumour cells of the Mer phenotype. Cancer Res 46: 5009-5013
11. McBain JA, Eastman A, Nobel CS and Mueller GC (1997) Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol 53: 1357-1368
12. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytoxicity assays. J Immunol Methods 65: 55-63
13. Musk P, Clark JM, Thompson D, Dunn IS, Christopherson RI, Szabados E, Rose SE and Parsons PG (1996) Purine deoxynucleoside metabolism in human melanoma cells with a high spontaneous mutation rate. Mutat Res 350: 229-238
14. Nakamura T, Okuyama S, Okamoto S, Nakajima T, Sekiya S and Oda K (1995) Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site. Exp Cell Res 216: 422-430
15. Palitti F, Carotti D, Busiello V, Bendicenti A, Strom R and DiGirolamo M (1993) DNA hypomethylation and differentiation in Friend leukemia cell variants. Biochim Biophys Acta 1216: 50-54
16. Parsons PG, Favier D, McEwan M, Takahashi H, Jimbow K and Ito S (1991) Action of cysteaminyl phenols on human melanoma cells in vivo and in vitro: 4-S-cysteaminylphenol binds protein disulphide isomerase. Melanoma Res I: 97-104
17. Parsons PG, Hansen C, Fairlie DP, West ML, Danoy P, Sturm RA, Dunn IS, Pedley J and Ablett E (1997) Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells. Biochem Pharmacol 53: 1719-1724
18. Perrine SP, Olivieri NF, Faller DV, Vichinsky EP, Dover GJ and Ginder GD (1994) Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders. Am J Ped Hematol Oncol 16: 67-71
19. Rasmussen HS and McCann PP (1997) Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimatstat and maximastat. Pharmacol Therap 75: 69-75
20. Richon VM and Ventaperez G (1996) Changes in E2F DNA-binding activity during induced erythroid differentiation. Cell Growth Diff 7: 31-42
21. Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA and Monks PA (1996) Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc Natl Acad Sci USA 93: 5705-5708
22. Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA and Marks PA (1998) A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci USA 95: 3003-3007
23. Rifkind RA, Richon VM and Monks PA (1996) Induced differentiation, the cell cycle and the treatment of cancer. Pharmacol Therap 69: 97-102
24. Rowinsky EK, Conley BA, Jones RJ, Spivak JL, Auerbach M and Donehower RC (1992) HMBA in myelodysplastic syndrome: effect of five day exposure to maximal therapeutic concentrations. Leukemia 6: 526-534
25. Saito S, Crissman HA, Nishijiima M, Kagahu T, Nishiya I and Cram LS (1991) Flow cytometric and biochemical analysis of dose-dependent effects of sodium butyrate on human endometrial adenocarcinoma cells. Cytometry 12: 757-764
26. Schroy PC, Rustgi AK, Ikonomu E, Liu XP, Polito J, Andry C and O'Keane JC (1994) Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells. J Cell Physiol 161: 111-123
27. Stoker A and Dutla R (1998) Protein tyrosine phosphatases and neural development. BioEssays 20: 463-472
28. Thyberg J, Hultgardh-Nilsson A and Kallin B (1995) Inhibitors of ADP-ribosylation suppress phenotypic modulation and proliferation of smooth muscle cells cultured from rat aorta. Differentiation 59: 243-252
29. Wang X, Hafezparast M and Masters JR (1996) Genetic basis of drug sensitivity in human testis tumour cells. Int J Cancer 65: 426-431
30. Wolffe AP and Pruss D (1996) Targetting chromatin disruption: transcription regulators that acetylate histones. Cell 84: 817-819
31. Yoshida M, Horinouchi S and Beppu T (1995) Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. BioEssays 17: 423-430